Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 2
2001 2
2002 1
2003 1
2004 2
2005 1
2006 6
2007 6
2008 5
2009 5
2010 8
2011 12
2012 11
2013 17
2014 18
2015 22
2016 32
2017 40
2018 33
2019 21
2020 31
2021 12
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 27103025

248 results
Results by year
Filters applied: . Clear all
Page 1
18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
Humbert O, Riedinger JM, Vrigneaud JM, Kanoun S, Dygai-Cochet I, Berriolo-Riedinger A, Toubeau M, Depardon E, Lassere M, Tisserand S, Fumoleau P, Brunotte F, Cochet A. Humbert O, et al. J Nucl Med. 2016 Nov;57(11):1707-1712. doi: 10.2967/jnumed.116.172759. Epub 2016 Apr 21. J Nucl Med. 2016. PMID: 27103025 Free article. Clinical Trial.
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
Groheux D, Biard L, Lehmann-Che J, Teixeira L, Bouhidel FA, Poirot B, Bertheau P, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, de Cremoux P. Groheux D, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4. Eur J Nucl Med Mol Imaging. 2018. PMID: 29616304
248 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page